Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Chikungunya vaccine live - Valneva

Next Previous
Drug Profile

Chikungunya vaccine live - Valneva

Alternative Names: Chikungunya vaccine, live; Chikungunya virus vaccine - Valneva; IXCHIQ; Live-attenuated Chikungunya Vaccine - Valneva; Live-attenuated CHIKV - Valneva; Single-Shot Chikungunya Vaccine - Valneva; VLA-1553

Latest Information Update: 13 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Valneva
  • Developer Butantan Institute; Valneva
  • Class Attenuated vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Chikungunya virus infections

Most Recent Events

  • 05 Jun 2025 Adverse events and immunogenicity data from a phase II trial in Chikungunya virus infections released by Valneva
  • 05 Jun 2025 Valneva plans a phase-III trial for Chikungunya virus infections (In children, Prevention) in the first quarter of 2026
  • 19 May 2025 Valneva ianticipates formal reviews of the post-marketing safety reports in all approved territories of Chikungunya vaccine live

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top